Tiziana Life Sciences PLC (NASDAQ:TLSA)
| 4.84 Delayed Data As of 3:59pm ET |  +0.38 / +8.52%Today’s Change | 0.62 Today|||52-Week Range 12.17 | +348.15% Year-to-Date |
Latest TLSA News | Press Releases
| Tiziana submits patent application for expanded use of Foralumab in COVID-19 Jul 31 / Seeking Alpha - Paid Partner Content | BLNK, PEIX, GTX and QEP among midday movers Jul 30 / Seeking Alpha - Paid Partner Content |
| BLNK, PEIX, GTX and BEP among midday movers Jul 30 / Seeking Alpha - Paid Partner Content |
Today’s Trading
| Previous close | 4.46 |
| Today’s open | 4.42 |
| Day’s range | 4.42 - 4.90 |
| Volume | 24,314 |
| Average volume (3 months) | 1,339,604 |
| Market cap | $490.7M |
Data as of 3:59pm ET, 08/13/2020
Growth & Valuation
| Earnings growth (last year) | -8.00% |
| Earnings growth (this year) | -4.40% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| APTOAptose Biosciences I... | +0.21 | +4.34% |
| RIGLRigel Pharmaceutical... | +0.00 | +0.20% |
| PFNXPfenex Inc | -0.09 | -0.70% |
| VYGRVoyager Therapeutics... | +0.18 | +1.62% |
Data as of 3:59pm ET, 08/13/2020
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$9.3M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters London, Greater London |
Forecasts
